← Leaderboards
Lawrence G Lum
Roger Williams Hospital
$8,498,201
Attributed
$10,435,655
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$10,435,655 · 3
By mechanism
R01$10,435,655 · 3
Top collaborators
- Nai-Kong V Cheung6 shared
Others in their field
Top investigators on “Cytotoxicity”
- David Heimbrook · Leidos Biomedical Research, Inc.$60,494,681
- Philip J Disaia · University Of California Irvine$58,213,103
- Kent J. Weinhold · Duke University$45,381,151
- Brenda J. Weigel · University Of Minnesota$36,792,183
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$34,242,475
- Douglas F Nixon · J. David Gladstone Institutes$30,748,895
Research focus
CytotoxicityWomanMalignant Breast NeoplasmErbb2 GeneTumorImmunotherapyPeripheral Blood Mononuclear CellT-LymphocytePhase Ii Clinical TrialsResponseImmuneInfusion ProceduresImmune ResponseBaseCellsMonitorCytokineBispecific AntibodiesBloodChemotherapyCd3 AntigensStagingNeoplastic CellHigh Risk
Grant awards (21)
Targeting Neuroblastoma with armed T cells$730,382
R01 · FY2019 · CA · contact PI
Targeting Neuroblastoma with armed T cells$1
R01 · FY2018 · CA · contact PI
Targeting Neuroblastoma with armed T cells$765,563
R01 · FY2017 · CA · contact PI
Targeting Neuroblastoma with armed T cells$822,924
R01 · FY2016 · CA · contact PI
Targeting Neuroblastoma with armed T cells$753,575
R01 · FY2015 · CA · contact PI
Targeting Neuroblastoma with armed T cells$802,464
R01 · FY2014 · CA · contact PI
Enhancing neoadjuvant chemotherpay responses with targeted T cells$1
R01 · FY2014 · CA · contact PI
Enhancing neoadjuvant chemotherpay responses with targeted T cells$468,081
R01 · FY2013 · CA · contact PI
Enhancing neoadjuvant chemotherpay responses with targeted T cells$500,120
R01 · FY2012 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$478,954
R01 · FY2012 · CA · contact PI
Enhancing neoadjuvant chemotherpay responses with targeted T cells$502,349
R01 · FY2011 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$480,343
R01 · FY2011 · CA · contact PI
Enhancing neoadjuvant chemotherpay responses with targeted T cells$519,027
R01 · FY2010 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$501,546
R01 · FY2010 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$501,226
R01 · FY2009 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$482,535
R01 · FY2006 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$49,176
R01 · FY2006 · CA · contact PI
Breast Cancer Treatment with Antibody Targeted T Cells$532,485
R01 · FY2005 · CA
Breast Cancer Treatment with Antibody Targeted T Cells$520,390
R01 · FY2004 · CA
Breast Cancer Treatment with Antibody Targeted T Cells$510,852
R01 · FY2003 · CA
Breast Cancer Treatment with Antibody Targeted T Cells$513,661
R01 · FY2002 · CA